305 related articles for article (PubMed ID: 28924049)
1. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
[TBL] [Abstract][Full Text] [Related]
2. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
[TBL] [Abstract][Full Text] [Related]
3. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
[TBL] [Abstract][Full Text] [Related]
4. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
5. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
[TBL] [Abstract][Full Text] [Related]
6. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
7. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
10. Humanized GPIbα-von Willebrand factor interaction in the mouse.
Kanaji S; Orje JN; Kanaji T; Kamikubo Y; Morodomi Y; Chen Y; Zarpellon A; Eberhardt J; Forli S; Fahs SA; Sood R; Haberichter SL; Montgomery RR; Ruggeri ZM
Blood Adv; 2018 Oct; 2(19):2522-2532. PubMed ID: 30287479
[TBL] [Abstract][Full Text] [Related]
11. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
12. Oxidation shuts down an auto-inhibitory mechanism of von Willebrand factor.
Tsai R; Interlandi G
Proteins; 2021 Jun; 89(6):731-741. PubMed ID: 33550613
[TBL] [Abstract][Full Text] [Related]
13. Delimiting the autoinhibitory module of von Willebrand factor.
Deng W; Voos KM; Colucci JK; Legan ER; Ortlund EA; Lollar P; Li R
J Thromb Haemost; 2018 Oct; 16(10):2097-2105. PubMed ID: 30053340
[TBL] [Abstract][Full Text] [Related]
14. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
[TBL] [Abstract][Full Text] [Related]
15. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.
Liu G; Fang Y; Wu J
J Biol Chem; 2013 Sep; 288(37):26658-67. PubMed ID: 23902764
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
[TBL] [Abstract][Full Text] [Related]
19. Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha.
Vasudevan S; Roberts JR; McClintock RA; Dent JA; Celikel R; Ware J; Varughese KI; Ruggeri ZM
J Biol Chem; 2000 Apr; 275(17):12763-8. PubMed ID: 10777573
[TBL] [Abstract][Full Text] [Related]
20. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain.
Cruz MA; Diacovo TG; Emsley J; Liddington R; Handin RI
J Biol Chem; 2000 Jun; 275(25):19098-105. PubMed ID: 10764791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
